Study Group: Silicone Hydrogel and Bausch and Lomb Contact Lens Prescribers: Ophthalmologists and Optometrists (US)
Council Members in this Study Group: 178
This study group may include physicians, care providers, and researchers specializing in internal medicine, cardiology, oncology, dermatology, emergency medicine, family medicine, neurology, obstetrics-gynecology, psychiatry, radiology, nursing, optometry, genetics, and mental health. It may also include experts knowledgeable on diagnostic labs, disease management, medical devices, long term care, surgery centers, health management, pharma, and biotechnology, among others.
Contact Gerson Lehrman Group to survey or consult with members of this Study Group
Leading institutions connect with members of this Study Group through GLG
Leading Experts in this Study Group
Gaurav ShahAssociate Professor of Ophthalmology
WASHINGTON UNIVERSITY MEDICAL CENTER
Gaurav Shah, MD, is an Associate Professor of Ophthalmology at the Washington University Medical Center in Missouri. He is a national expert in the care of patients with diabetic retinopathy/diabetic macular edema, age-related macular degeneration, retinal...
Barry SchechterDirector of Corneal and External Diseases
FLORIDA EYE MICROSURGICAL INSTITUTE INCBarry Schechter, MD, is the Director of Department of Cornea and External Disease at Florida Eye Microsurgical Institute. Dr. Schechter's practice involves diseases of the ocular surface including dry eyes, allergies, infection; the latest in corneal,...
- Andrew Dahl
President
Ophthalmology ConsultantsAndrew Dahl, MD, FACS, FAAO, is the President of Ophthalmology Consultants in New York. He was also Principal Investigator for Hudson Valley Eye Research Foundation and has conducted numerous clinical trials. Dr. Dahl is a board-certified Ophthalmologist/Ophthalmic...
- Hal Breedlove
Owner and Clinical Director
Coastal VisionHal Breedlove, OD, is the Owner and Clinical Director of Coastal Vision, a five Optometrist practice in Virginia Beach, Chesapeake, and Norfolk Virginia. In practice for over 26 years, he has expertise in a many areas of vision research, patient care,...
Steve RubinsteinOptometrist
Sound Shore Vision CareSteve Rubinstein, OD, is a Clinical Optometrist at Diamond District Eye Associates and Sound Shore Vision Center, office based practices in New York. Dr. Rubinstein has a biochemical background. He has won the Frank R. Blood award by the Society of Toxicology...
GLG NewsSM Analyses by this Study Group's Leading Experts(?)
Opinions and analyses expressed in GLG News are solely those of the author. See the Terms of Use for details.
-
Lumigan X EU Committee Recomendation
October 27, 2009
Analysis by: Andrew Dahl, President ,EU committee backs marketing approval of Lumigan | www.pharmabiz.com
The Committee for Medicinal Products for Human Use (CHMP) of the European Union has recommended granting a Marketing Authorization for a new version of Allergan's Lumigan (bimatoprost ophthalmic solution). This new version will be marketed as Lumigan-X after approval. Lumigan X offers Allergan a new formulation to compete against generic versions of its glaucoma drug Lumigan after patent protection for Lumigan expires shortly.There will be very limited demand for Lumigan-X.
-
Contact Lens Nirvana: Hyperpermeable One Day
October 2, 2009
Analysis by: Steve Rubinstein, Optometrist,Hobby assists Irish strategy | www.opticianonline.net
This article describes resources being put into place to mass produce the first commercially available silicon hydrogel one day disposable contact lens in the USA by Johnson & Johnson's Vistakon division.
-
Alcon, Novartis (Ciba Vision), Astra-Zeneca working on ocular medications?
July 23, 2009
Analysis by: Steve Rubinstein, Optometrist,Alcon Signs Agreement With AstraZeneca On Eye Drug Development | www.pharmaceutical-business-review.com
This agreement seems to allow Alcon Laboratories, Inc and Astra-Zeneca to work together to produce ocular medications. What it doesn't say is that they can also use Ciba Vision's resources in the near future.
-
Welcome addition to our armament, but overuse potential?
July 14, 2009
Analysis by: Gary Barker, Partner/Owner,Bausch and Lomb (BOL) Receives FDA Approval of Besivance(TM), New Topical Ophthalmic Antibacterial for the Treatment of Bacterial Conjunctivitis ('Pink Eye') | www.lifescience-online.com
Potential for overuse and more drug-resistant bacteria
-
A drop in the price of OTC allergy eye drops?
July 5, 2009
Analysis by: Steve Rubinstein, Optometrist,Sun Pharmaceutical gets tentative nod from USFDA for ‘Optivar Solution’ | Top News | www.topnews.in
By adding a third OTC antihistamine eye drop to the mix the price competition should make the cost to the consumer decrease.
Members in this Study Group include these company types:
- Office Based Private Practice or Clinic
- Academic Medical Center/Hospital or Clinic
- Non-Academic Community Hospital or Clinic
Members in this Study Group often have these job titles:
- Owner
- Physician - Attending Physician
- Allied Health Professional
- President
- Optometrist
- Partner
- Physician - Director
Related Study Groups
| Study Group Name | No. Members |
|---|---|
| Optometrists (US) | 283 |
| Optometrists | 370 |
| Physicians who Treat Dry Eye (US) | 129 |
| Prescribers of CooperVision HydraSoft Series (US) | 20 |
| Prescribers of CIBA Vision Torisoft Lenses (US) | 20 |
| Council Members in Member Programs who Treat Fusarium Keratitis | 51 |
| Ophthalmologists (US) | 1133 |
| Ophthalmologists | 1610 |
GLG Live Meetings with this Study Group's Leading Experts (?)
April 19, 2006 | New York
GLGi: Ophthalmology Grand RoundsGLG Webcasts & Teleconferences
Leading Experts in Silicone Hydrogel and Bausch and Lomb Contact Lens Prescribers: Ophthalmologists and Optometrists (US) have not participated in any GLG webcasts.